Print
Category: FDA Events and Happenings
Hits: 1770

Date: 22.01.2011

Launch of Indian Pharmacopoeia 2010 at the hands of Shri.Sanjay Kumar Srivastva, Chief Secretary. Also seen Dr.G.N.Singh, Director and Secretary of IP Commission, Dr.Ramkrishna, Deputy Drugs  Controller,CDSCO, West Zone, Shri.Salim Veljee, FDA Director, Mr.Arun Naik , Mr.A K Burman and  Suresh Kamath from GPMA.

Goa Pharmaceuticals Manufacturers’ Association (GPMA) organized a formal launch of new edition of Indian Pharmacopoeia (IP) 2010 and National Formulary of India (NFI) in Goa at the hands of  Shri.Sanjay Kumar Srivastva, Chief Secretary – Goa State in the presence of Dr.G .N.Singh, Director  and Secretary – IP Commission, Dr.Ramkrishna, Deputy Drugs Controller CDSCO, West Zone and Shri. Salim Veljee, Director FDA.

Dr.Singh informed that Indian Pharma companies have surpassed standards meeting all regulatory standards from EU and US, Australia  and other countries. It is necessary we update our Indian Pharmacopoeia on regular basis to meet the challenges of these countries. He expressed his vision that one day Indian Pharmacopoeia will exceed all the set standards and gain international status like United States Pharmacopoeia (USP), British Pharmacopoeia (BP) European Pharmacopoeia (EP). He also explained the benefits of National Formulary of India for various sections of users.

Shri Sanjay Kumar Srivastva in his presidential address complimented IP Commission for bringing out the latest edition of IP and NFI to catch up the growth in Indian Pharma market as well as exports. He agreed to help Pharma Industry in Goa for their various issues inhibiting their further growth in Goa . He is of opinion that non polluting Pharma Industry should be nurtured to benefit of Goa state in terms of revenue and employment generation and agreed for all help in this direction.

Mr.Arun Naik, GPMA President earlier welcomed dignitaries and audience and stressed the need of good infrastructure in Goa state like water, uninterrupted power supply, abolition of entry tax etc. In addition notification of Murmagoa Port Trust for export -import will reduce cost of transportation and easier cargo movement. GPMA has been pursuing with local FDA for a Zonal Office of CDSCO for import-export and WHO Certification which will benefit over 50 manufacturing units in their export obligations.

The session was attended by CEOs of Goa based companies, Unit and QA heads from various Pharma Units located in Goa, also officials from FDA Directorate, office bearers from Indian Pharmaceutical Association, Chemist and Druggist Association and  Pharmacy  College .